CRMD

Q: What is the price of CorMedix (CRMD) today?

The current price of CorMedix (CRMD) is $ 7.91, representing a -35.59% gain over the past year. The stock began the year trading around $ 11.63 and is currently priced at $ 7.91. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does CorMedix (CRMD) pay dividends?

CorMedix (CRMD) did not pay dividends over the past year.

Q: Is CorMedix (CRMD) a good investment?

CorMedix (CRMD) is currently trading at $ 7.91 with a P/E ratio of 15.65. This represents a -39,999,687% premium compared to its historical average P/E. Over the past year, the stock has gained -35.59 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -35.59%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

CorMedix Inc.

Price

$ 7.91

return (12m)

-35.59%

p/e

15.65

p/bv

1.38

DIVIDEND YIELD

0.00%

CRMD price

CRMD

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment CRMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

7.04%

3 months

9.71%

1 year

-35.59%

2 years

54.49%

5 years

17.19%

10 years

-42.05%

Fundamentals CRMD

review the fundamentals of CorMedix shares

P/E

15.65

Sector: -5.42 Industry: -0.51

P/S (PSR)

4.74

Sector: 5.64 Industry: 6.71

P/BV

1.38

Sector: 2.05 Industry: 2.31

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

4.73%

Sector: -12.31% Industry: -11.21%

ROE

8.83%

Sector: -13.04% Industry: -11.43%

ROIC

34.41%

Sector: -429.08% Industry: -92.89%

NET MARGIN

30.29%

Sector: -27.99% Industry: -29.53%

GROSS MARGIN

82.49%

Sector: 45.76% Industry: 50.66%

OPERATING MARGIN

49.96%

Sector: -25.89% Industry: -27.81%

EV/EBITDA

8.14

Sector: -0.59 Industry: 2.72

EV/EBIT

9.49

Sector: -5.83 Industry: 1.59

PRICE-TO-ASSETS

0.74

Sector: 1.13 Industry: 1.28

BVPS

5.46

Sector: 3.94 Industry: 5.19

EPS

0.48

Sector: -0.41 Industry: -0.30

EQUITY-TO-ASSETS RATIO

0.54

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

0.46

Sector: 0.47 Industry: 0.51

CAGR REVENUE 5 YEARS

357.32%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF CorMedix ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 7.91

Fair Value

$ 0.00

Upside/Downside Return potential.

-2.92%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals CRMD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	121.47	28.80	23.71%	0.62%	$ 898.40 B	37.36%
ISRG	181.98	8.50	4.67%	0.00%	$ 149.50 B	29.65%
TMO	98.77	3.13	3.17%	0.40%	$ 163.06 B	15.00%
SNY	44.47	1.24	2.79%	5.18%	$ 104.21 B	7.89%
NVS	89.57	7.26	8.11%	2.10%	$ 282.68 B	23.34%
ABT	25.14	0.00	0.00%	2.64%	$ 157.79 B	13.91%
MDT	85.48	1.99	2.32%	3.73%	$ 97.70 B	12.68%
GSK	42.79	4.27	9.97%	3.56%	$ 99.09 B	22.77%
CVS	41.48	1.57	3.79%	2.77%	$ 122.07 B	2.93%
BSX	21.94	3.00	13.66%	0.00%	$ 78.23 B	17.29%
TMDX	293.55	4.35	1.48%	0.00%	$ 2.15 B	4.21%
HCA	58.49	-31.82	-54.40%	0.70%	$ 94.75 B	8.48%
IDXX	151.92	27.19	17.89%	0.00%	$ 42.30 B	24.41%
RMD	73.41	4.51	6.14%	1.15%	$ 29.27 B	27.86%
DHR	111.40	2.16	1.94%	0.84%	$ 114.63 B	17.29%
INMD	75.75	1.32	1.75%	0.00%	$ 875.70 M	14.09%
PHG	137.64	1.82	1.32%	3.51%	$ 24.03 B	3.87%
VTRS	107.91	1.30	1.20%	2.91%	$ 19.03 B	5.02%
SYK	157.25	5.10	3.24%	1.12%	$ 117.15 B	12.38%
FMS	87.46	0.72	0.83%	3.64%	$ 11.88 B	2.55%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

CRMD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT CorMedix

CorMedix Inc.

Average Investor10 user rating

4.0 (2 people)

United States

20 years

Founded: 2006

2010

Time since IPO - 16 years

35

Employees

CorMedix Inc. (United States) is listed on the Nasdaq and has a market capitalization of $604.00 Millions, with shareholders equity totaling $437.05 Millions.

The company employs approximately 35 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, CorMedix Inc. reported $400.07 Millions in revenue, generating net income of $181.01 Millions.

Key financial metrics include a P/E ratio of 15.65, a price-to-book (P/B) ratio of 1.38, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CRMD.

Market cap

$ 604.00 Millions

Net worth

$ 437.05 Millions

$ 437,050,000.00

Assets

$ 815.64 Millions

$ 815,640,000.00

Total Shares Outstanding

80.00 Millions

80,000,000

Average Daily Trading Volume

$ 1.30 Million

$ 1,295,057.52

Sector

Health

Industry

Pharmaceutical Products

CRMD

CRMD revenue and profits

Financial Results CRMD

DRAG THE FRAME TO SEE MORE DATA

CRMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CVS - CVS Health

$ 95.99 58,50% (12M)

P/E

41.48

2.77%

ROE

3.79%

P/BV

1.57

CI - Cigna

$ 286.69 --8,58% (12M)

P/E

45.53

2.13%

ROE

3.90%

P/BV

1.77

CNC - Centene

$ 58.23 --5,39% (12M)

P/E

18.60

0.00%

ROE

7.16%

P/BV

1.33

HUM - Humana

$ 306.00 26,03% (12M)

P/E

30.87

1.16%

ROE

6.36%

P/BV

1.96

SNY - Sanofi

$ 43.54 --9,61% (12M)

P/E

44.47

5.18%

ROE

2.79%

P/BV

1.24

LLY - Eli Lilly

$ 988.09 33,46% (12M)

P/E

121.47

0.62%

ROE

23.71%

P/BV

28.80

HCA - HCA Healthcare

$ 422.79 10,21% (12M)

P/E

58.49

0.70%

ROE

-54.40%

P/BV

-31.82

NVS - Novartis

$ 149.15 37,34% (12M)

P/E

89.57

2.10%

ROE

8.11%

P/BV

7.26